You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Along with the federal settlement, the company will also pay an additional $13.2 million to settle civil claims by different state attorneys general.
The Verge reports the US has charged two individuals who allegedly work with the Chinese government with stealing trade secrets.
The US DOJ alleged that the company conspired to "artificially delay" ordering its MammaPrint test in order to circumvent Medicare's 14-day rule.
Sanofi has been hit with a nearly $12 million fine for supporting a charity that covered the costs of co-pays for Medicare patients taking an expensive drug sold by the firm.
A US attorney tells ScienceInsider that charges are being pursued against Harvard University's Charles Lieber due to the amount of money he allegedly received and failed to disclose.
The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.
According to the DOJ, the company also accepted a 25-year ban on participating in any federal healthcare program.
Arrests have been made and charges filed in connection with a genetic testing fraud scheme, Reuters reports.
The Justice Department has issued an interim policy governing the use of genetic genealogy, according to CNET.
The company decided to settle the complaint in order to avoid "lengthy and distracting litigation," but denies any wrongdoing.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.